Teva Pharmaceuticals v. Sandoz, Inc.: Supreme Court orders “clear error” review for claim construction appeals.

The high court issued its opinion today in Teva Pharmaceuticals v. Sandoz, Inc. holding:  When reviewing a district court’s resolution of subsidiary factual matters made in the course of its construction of a patent claim, the Federal Circuit must apply a “clear error,” not a de novo, standard of review.

A victory for drugmaker Teva Pharmaceuticals USA Inc.

Full opinion here.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s